News | February 25, 2013

American Heart Association Focuses on Newborn Screenings for Congenital Heart Defects

Pulse oximetry can save lives by detecting heart defects otherwise missed

AHA Newborn Screenings for Congenital Heart Defects Pulse Oximetry

February 25, 2013 — The American Heart Association (AHA) is focusing its advocacy efforts across the Midwest on the use of pulse oximetry screening (pulse ox) to detect congenital heart defects in newborns.

"Pulse ox screening is non-invasive, inexpensive and can potentially save a child's life," said Maureen Cassidy, vice president of Advocacy for the American Heart Association's Midwest Affiliate. "In fact, new research suggests that wider use of pulse ox would help identify more than 90 percent of heart defects."

The test consists of sensors placed on a newborn's hand and foot to check blood oxygen levels. If levels are too low, additional tests may be conducted that aid in detecting critical or possibly life-threatening heart defects that might otherwise go undetected.

In September 2011, U.S. Secretary of Health and Human Services Kathleen Sebelius advised that critical congenital heart defects screening be added to the "Recommended Uniform Screening Panel" for newborns before they are released from a hospital or birthing facility. As a result, several states including New Jersey, Maryland, Indiana, Tennessee and West Virginia have already passed laws requiring newborns to have pulse ox screenings prior to being discharged from the hospital.

Ongoing advocacy efforts across the Midwest include:

  • Illinois – The AHA is working with volunteers, partner organizations and the Department of Public Health to pass pulse ox legislation.
  • Indiana – In spring 2011, the Indiana legislature added pulse ox to the state's newborn screening and all birthing facilities in Indiana are now required to perform this screening.
  • Iowa – Legislation has been introduced to require all hospitals to administer pulse ox screening to every newborn. The AHA continues to work with the Iowa Health Department to add this test to the screening panel.
  • Kansas – The AHA is working with the Kansas Newborn Screening Advisory Council to recommend that pulse ox screening be added to the list of tests conducted on all Kansasnewborns prior to discharge. The formal recommendation is expected later this spring.
  • Michigan – The AHA is supporting the Michigan Dept. of Community Health in coordinating a pilot study to establish best practices in pulse ox screening for the state. Educational materials can be found at
  • Minnesota – The state introduced legislation this February to make pulse ox screening required for all newborns before hospital discharge.
  • Missouri – Chloe's Law (Senate Bill 230/House Bill 274) has been introduced and would require all birthing facilities in Missouri to screen newborns using pulse ox. Both bills are scheduled to be heard in committee and could be discussed on the floor of each chamber as early as March.
  • Nebraska – The AHA is working with volunteers and partner organizations to pass screenings for all newborns in Nebraska. The bill passed an initial vote of 40-0 and must now continue through the legislature.
  • North Dakota – A North Dakota bill has passed the Senate by a 47 – 0 vote after a unanimous "Do Pass" recommendation by the Senate Human Services committee.
  • Ohio – The "Newborn Healthy Hearts Bill" (Senate Bill 4) has been introduced to include pulse oximetry screening to the newborn screening panel. The bill is a senate top 10 priority.
  • South Dakota – Senate Bill 168 (SB168) to require pulse ox screening for newborns is currently moving through the South Dakota Legislature, gaining broad, bipartisan support.
  • Wisconsin – Legislation with strong, bi-partisan support and a broad group of stakeholder support was circulated in early February and is expected to be introduced in early March.


To learn more about the efforts to increase pulse ox screening among newborns, visit


Related Content

News | Patient Monitors | March 09, 2018
Philips recently announced the integration of its IntelliVue Guardian with automated Early Warning Scoring (EWS) into...
Acarix, CADScor System, coronary artery disease detection, clinical study, ACC.17
News | Patient Monitors | March 30, 2017
Acarix AB recently announced the results from a new multi-center trial of its handheld CADScor System for non-invasive...
Corsens Medical, Corsens Cardiac Monitor, FDA 510(k) clearance
Technology | Patient Monitors | December 08, 2016
Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k)) with the U.S....
Corsens Cardiac Monitor, FDA 510k pre-market notification
News | Patient Monitors | May 26, 2016
Corsens Medical Ltd. announced it has successfully completed filing of a Pre-Marketing Notification (510(k)) with the U...
Philips, FDA 510k clearance, Expression MR400, MRI patient monitor
Technology | Patient Monitors | February 11, 2016
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new...
Profusa, integrated biosensors, long-term continuous monitoring
News | Patient Monitors | January 15, 2016
Biointegrated sensors for long-term, continuous tracking of body chemistry may make health and disease monitoring as...
sleep apnea, pulse oximetery, congestive heart failure, CHF, pulse-oximetry, Thomas Jefferson University
News | Patient Monitors | September 09, 2015
Researchers at Thomas Jefferson University showed that a simple questionnaire, evaluation and pulse-oximetry monitoring...
Nonin Medical, NoninConnect Model 3230, Bluetooth Smart, wireless finger pulse oximeter, iOS-compatible, Apple

Image courtesy of Nonin Medical

Technology | Patient Monitors | August 14, 2015
August 14, 2015 — Nonin Medical Inc.
News | Patient Monitors | June 09, 2015
Start-up company GraftWorx was chosen as "Best in Show" at the Mid-Atlantic Bio Angels (MABA) 1st Pitch Life Science...
Overlay Init